“…This structured approach provides valuable insights into the factors that may influence the clinical management of CB. In previous research, device-related arrhythmia was induced by localized inflammation and aggressive myocardial fibrosis 37 . Our analysis of PBMCs mRNA from patients of occluder implantation for VSD closure showed a significantly elevated m 6 A level in the PCB group compared to NCB and TCB patients, as determined by dot blot and colorimetric assays ( Figure 2 A - B ).…”